-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
SOLUTIONS
-
Research & Development
-
Real World Evidence
-
Commercialization
-
Safety & Regulatory Compliance
-
Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
- Information Partner Services
- Financial Institutions
- Global Public Health
- Government
- Patient Associations
- Payers
- Providers
THERAPEUTIC AREAS
- Cardiovascular
- Cell and Gene Therapy
- Central Nervous System
- GI & Hepatology
- Infectious Diseases and Vaccines
- Oncology
- Pediatrics
- Rare Diseases
- View All
Impacting People's Lives
"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MORE
Harness the power to transform clinical development
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewResearch & Development Quick Links
Real World Evidence. Real Confidence. Real Results.
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWReal World Evidence Quick Links
See markets more clearly. Opportunities more often.
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWCommercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWSafety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWTechnology Quick Links
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
BLOGS, WHITE PAPERS & CASE STUDIES
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSTHE IQVIA INSTITUTE
An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTS
FEATURED INNOVATIONS
-
IQVIA Connected Intelligence™
-
IQVIA Healthcare-grade AI™
-
IQVIA AI Assistant
-
Human Data Science Cloud
-
IQVIA Innovation Hub
-
Decentralized Trials
-
Patient Experience Solutions with Apple devices
WHO WE ARE
- Our Story
- Our Impact
- Commitment to Public Health
- Code of Conduct
- Environmental Social Governance
- Privacy
- Executive Team
NEWS & RESOURCES
Unlock your potential to drive healthcare forward
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
IQVIA AI is Healthcare-grade AI
Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MORE
Meet the IQVIA AI Assistant
Your new expert analyst is here. Be at the forefront of data-driven decision-making with a new generative AI tool that enables you to interact with our products and solutions like never before. Get results you can trust, faster.
LEARN MORE
Your healthcare data deserves more than just a cloud.
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
Proven, faster DCT solutions
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
IQVIA Patient Experience Solutions with Apple devices
Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MOREWORKING AT IQVIA
Our mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.
LEARN MORELIFE AT IQVIA
Careers, culture and everything in between. Find out what’s going on right here, right now.
LEARN MORE
WE’RE HIRING
"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
SEARCH JOBSBlog
Patient engagement drives commercial strategy
How to use precise patient identification to improve your European brand opportunity
Oct 21, 2022
We often talk about the importance of capturing the patient perspective in clinical trials. But these insights can add tremendous value across the commercial product lifecycle.
When leveraged as part of the commercial strategy, real-world patient data can help pharma companies get the right products to the right patients at the right time in order to improve patient outcomes.
Prior to launch, these insights help pharma leaders better understand the current disease landscape, patient characteristics and unmet need, build budget impact models, and establish brand messaging and outreach plans. Once a product is in the market, real-world patient data can be used to identify relevant healthcare professionals (HCPs) who treat patients of interest, and to embed tools in clinical practice to inform treatment decisions to improve population health.
All of this adds value across the stakeholder landscape. But it only works if pharma companies have the access, technology, and local domain expertise to use real-world patient data as part of their commercial plan. European markets in particular present unique challenges around the availability of data sources. Strict data privacy regulations, the fragmentation of data sources across primary and secondary care, and the decentralization of decision-making are the main limitations.
In a recent webinar, entitled Improve Your Brand Opportunity Using Precise Patient Identification, IQVIA’s real-world patient data experts, Ban Tawfik, Andrea Seltmann, and Ashley Pitcher, discussed how companies can leverage advanced analytics with real-world data throughout the product lifecycle, and how it can add value at every step in this journey.
All your questions answered
Patient identification is the foundation for everything pharma does. Knowing who the patient is, how they suffer, and what outcomes will improve their quality of life is the basis of research and the framework for commercial strategy.
Gathering these insights is even more critical now that the industry is shifting to niche indications with narrow patient populations. Finding, diagnosing, and treating these patients is more complicated today, but it can be done.
The volume and variety of real-world patient data now available offers an untapped gold mine of insights about patients of interest. These insights can be found in structured data sets, like disease registries, electronic medical records, and pharmacy reports, along with less structured resources including genomics data, literature reviews, social media, and images captured from labs and connected devices.
All of these resources hold valuable information. But with so much data, it is getting harder to uncover useful insights to rapidly support decision-making.
These real-world data sets can be fragmented, delivery options are often limited, and each country and owner adheres to a different set of data privacy rules, which can limit accessibility.
Proof it works
To overcome these obstacles, pharma companies need a real-world commercial data plan that includes the data, technology, and expertise they will use to find the results they need. IQVIA brings all of these assets to the table. We have one of the largest real-world databases in the world, along with scalable infrastructure that can run AI-driven analytics, and a team of experts who build algorithms for each function and purpose.
IQVIA’s experts have built dozens of algorithms that have helped clients support medical, commercial, and health system decisions as part of their commercial strategy.
In one project, IQVIA worked with a clinical commissioning group and clinical experts to develop an algorithm based on clinical rules to identify patients with heart failure who were not already on the appropriate heart failure register. Presence on the register is important both for GP practice reimbursement and to ensure that patients are receiving the appropriate care and treatment for their condition.
When assessing the impact of the algorithm, the pilot program identified more than 1000 patients to be added to the heart failure register or left ventricular systolic dysfunction register across 12 pilot practices. This resulted in additional revenue of more than £113,000 for the pilot practices, and the algorithm is now used by over 1000 practices today. IQVIA has subsequently demonstrated that AI can be used to further increase the precision of heart failure patient identification.
Plan for the future
Building such algorithms requires a deep understanding of the disease area, the data available, and how it is being collected. When pharma companies combine the right data, advanced technology, and industry expertise, they can create AI-driven solutions that transform the mass of real-world data into useful insights to support medical, commercial, and health system decisions.
You can view the entire webinar here or contact an expert to learn more about IQVIA’s approach to real-world patient analytics.